Blood Glucose Control

A recent study showed that it might be a good idea to start eating dinner earlier in the day to help keep those blood glucose levels in control.

Smart contact lenses are capable of tracking tear glucose levels and delivering drug therapy directly to the retina.

A woman, 72 years of age, type 2 diabetes, obesity, taking metformin, GLP1, ARB, and antidepressant (SSRI). Lost 20% total body weight in the past year. Recently complaining of dizziness and weakness. Glucose levels in the 60’s at home, at which time had symptoms of hypoglycemia. Glucose-lowering medications (metformin and GLP-1) were stopped. Continued to complain of dizziness and weakness especially in the morning.

Can variability in HbA1c lead to a higher risk of mortality in persons with diabetes?

Man, 52 years of age, type 2 diabetes, obesity class II on Victoza. He was very pleased with treatment response, lowering glucose levels, feeling full and more satisfied, but having a skin reaction.

Dasiglucagon is a glucagon analog stable in an aqueous formulation with FDA approval for severe hypoglycemia use. The target population is patients with diabetes who are six years of age and older, but how effective is it among other subgroups?

How does basal insulin compare to other diabetes medications in its impact on cholesterol and triglycerides?

Several warnings have been issued by the CDC regarding unsafe practices that might result in the transmission of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and other infectious diseases during assisted blood glucose monitoring and insulin administration.

A study was conducted to assess if HbA1c variability impacts the incidence of diabetic complications, all-cause and cardiovascular mortality. 

HbA1c variability and swings between hypo- and hyperglycemia can increase risk of developing cardiovascular disease.